• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Burton highlights the benefits of Aquablation therapy

Video

“Men with and without retention all do very well from the voiding standpoint with relatively low rates of complications,” says Claire S. Burton, MD.

In this video, Claire S. Burton, MD, highlights take-home messages based on findings from the study, “Outcomes of Aquablation in men with acute and chronic urinary retention,” for which she served as the lead author. Burton is an FPMRS fellow at Standford University in California.

Video Transcript:

I think overall, it just adds to the literature that supports that Aquablation is an effective tool and supports that it is an effective tool for men with urinary retention, and really all-comers, especially those who really wished to preserve their ejaculatory and erectile function. We know that over 90% of men preserve ejaculation with this therapy, which is really what makes it stand out from some of the other more resective or more aggressive prostate treatments. But men with and without retention all do very well from the voiding standpoint with relatively low rates of complications and are able to preserve that, so I think this just adds to the literature and is supportive of the use of this technology in pretty much all-comers. We know it can treat a variety of prostate sizes, so it's a nice treatment that is a great option for many men.

This transcription has been edited for clarity.

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
DNA helix | Image Credit: © Siarhei - stock.adobe.com
Jenny Guo, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Samuel L. Washington III, MD, MAS, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.